Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 5
Submit an article Journal homepage
450
Views
40
CrossRef citations to date
0
Altmetric
Reviews

Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects

David M. GoldenbergGarden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey, USACorrespondence[email protected]
,
Franck MorschhauserService des Maladies du Sang, Centre Hospitalier Regional, Lille, France
&
William A. WegenerImmunomedics, Inc., Morris Plains, New Jersey, USA
Pages 747-755 | Received 14 Dec 2009, Accepted 02 Feb 2010, Published online: 09 Mar 2010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.